{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Toxoplasmose : Questions médicales les plus fréquentes",
"headline": "Toxoplasmose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Toxoplasmose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-26",
"dateModified": "2025-02-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Toxoplasmose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coccidiose",
"url": "https://questionsmedicales.fr/mesh/D003048",
"about": {
"@type": "MedicalCondition",
"name": "Coccidiose",
"code": {
"@type": "MedicalCode",
"code": "D003048",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.610.752.250"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Toxoplasmose",
"alternateName": "Toxoplasmosis",
"code": {
"@type": "MedicalCode",
"code": "D014123",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J P Dubey",
"url": "https://questionsmedicales.fr/author/J%20P%20Dubey",
"affiliation": {
"@type": "Organization",
"name": "United States Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Building 1001, Beltsville, MD 20705-2350, USA."
}
},
{
"@type": "Person",
"name": "João M Furtado",
"url": "https://questionsmedicales.fr/author/Jo%C3%A3o%20M%20Furtado",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; Formerly of Casey Eye Institute, Oregon Health & Science University, USA."
}
},
{
"@type": "Person",
"name": "Uwe Pleyer",
"url": "https://questionsmedicales.fr/author/Uwe%20Pleyer",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Charité Campus Virchow, University Faculty of Medicine, Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Institute of Medical Microbiology and German Reference Laboratory for Toxoplasma Infection, Faculty of Medicine University of Göttingen; Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School (MHH); Unit 35: Gastrointestinal Infections, Zoonoses and Tropical Infections, Robert Koch Institute, Berlin; Unit 16: Mycotic and parasitic agents and mycobacteria, Robert Koch Institute, Berlin."
}
},
{
"@type": "Person",
"name": "Rubens Belfort",
"url": "https://questionsmedicales.fr/author/Rubens%20Belfort",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Federal University of São Paulo, Paulista Medical School, São Paulo, SP, Brazil; Vision Institute, São Paulo, SP, Brazil."
}
},
{
"@type": "Person",
"name": "Padmamalini Mahendradas",
"url": "https://questionsmedicales.fr/author/Padmamalini%20Mahendradas",
"affiliation": {
"@type": "Organization",
"name": "Department of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "AI + Ethics Curricula for Middle School Youth: Lessons Learned from Three Project-Based Curricula.",
"datePublished": "2022-08-01",
"url": "https://questionsmedicales.fr/article/35935456",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40593-022-00298-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Aetiology and outcomes of prolonged neonatal jaundice in tertiary centres: data from the China Neonatal Genome Project.",
"datePublished": "2022-07-18",
"url": "https://questionsmedicales.fr/article/35851034",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/archdischild-2021-323413"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lessons learnt from delivering the public and patient involvement forums within a younger onset dementia project.",
"datePublished": "2022-07-14",
"url": "https://questionsmedicales.fr/article/35833723",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/14713012221110006"
}
},
{
"@type": "ScholarlyArticle",
"name": "How well have CMIP3, CMIP5 and CMIP6 future climate projections portrayed the recently observed warming.",
"datePublished": "2022-07-14",
"url": "https://questionsmedicales.fr/article/35835803",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-16264-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Secular Trends in the Burden of Multiple Myeloma From 1990 to 2019 and Its Projection Until 2044 in China.",
"datePublished": "2022-07-08",
"url": "https://questionsmedicales.fr/article/35875035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2022.938770"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies parasitaires",
"item": "https://questionsmedicales.fr/mesh/D010272"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protozooses",
"item": "https://questionsmedicales.fr/mesh/D011528"
},
{
"@type": "ListItem",
"position": 5,
"name": "Coccidiose",
"item": "https://questionsmedicales.fr/mesh/D003048"
},
{
"@type": "ListItem",
"position": 6,
"name": "Toxoplasmose",
"item": "https://questionsmedicales.fr/mesh/D014123"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Toxoplasmose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Toxoplasmose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Toxoplasmose",
"description": "Comment diagnostique-t-on la toxoplasmose ?\nQuels tests sont utilisés pour la toxoplasmose ?\nLa biopsie est-elle nécessaire pour diagnostiquer la toxoplasmose ?\nPeut-on diagnostiquer la toxoplasmose par imagerie ?\nQuels symptômes indiquent un test de toxoplasmose ?",
"url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Pilot+Projects&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Toxoplasmose",
"description": "Quels sont les symptômes courants de la toxoplasmose ?\nLa toxoplasmose peut-elle être asymptomatique ?\nQuels symptômes chez les immunodéprimés ?\nY a-t-il des symptômes spécifiques chez les femmes enceintes ?\nComment se manifeste la toxoplasmose oculaire ?",
"url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Pilot+Projects&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Toxoplasmose",
"description": "Comment prévenir la toxoplasmose ?\nLes femmes enceintes doivent-elles prendre des précautions ?\nLe lavage des mains aide-t-il à prévenir la toxoplasmose ?\nLes chats peuvent-ils transmettre la toxoplasmose ?\nLes jardins potagers présentent-ils un risque ?",
"url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Pilot+Projects&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Toxoplasmose",
"description": "Quel est le traitement standard de la toxoplasmose ?\nLes antibiotiques sont-ils efficaces contre la toxoplasmose ?\nLe traitement est-il nécessaire pour tous les cas ?\nCombien de temps dure le traitement de la toxoplasmose ?\nY a-t-il des effets secondaires au traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Pilot+Projects&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Toxoplasmose",
"description": "Quelles sont les complications possibles de la toxoplasmose ?\nLa toxoplasmose peut-elle affecter le fœtus ?\nQuels risques pour les personnes immunodéprimées ?\nLa toxoplasmose peut-elle causer des problèmes neurologiques ?\nY a-t-il un risque de réinfection ?",
"url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Pilot+Projects&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Toxoplasmose",
"description": "Qui est le plus à risque de toxoplasmose ?\nLes personnes âgées sont-elles plus à risque ?\nLes jardiniers sont-ils à risque ?\nLes voyageurs dans certains pays sont-ils à risque ?\nLes personnes qui consomment de la viande crue sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Pilot+Projects&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la toxoplasmose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques détectant les anticorps anti-Toxoplasma."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la toxoplasmose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests IgG et IgM sont couramment utilisés pour évaluer l'infection."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle nécessaire pour diagnostiquer la toxoplasmose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie est rarement nécessaire, sauf en cas de complications neurologiques."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer la toxoplasmose par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'imagerie cérébrale peut montrer des lésions typiques chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un test de toxoplasmose ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre, la fatigue ou des douleurs musculaires peuvent justifier un test."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la toxoplasmose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, fatigue, douleurs musculaires et ganglions enflés."
}
},
{
"@type": "Question",
"name": "La toxoplasmose peut-elle être asymptomatique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses personnes infectées ne présentent aucun symptôme visible."
}
},
{
"@type": "Question",
"name": "Quels symptômes chez les immunodéprimés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Chez les immunodéprimés, la toxoplasmose peut provoquer des symptômes neurologiques graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les femmes enceintes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes enceintes peuvent transmettre l'infection au fœtus, entraînant des malformations."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la toxoplasmose oculaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La toxoplasmose oculaire peut provoquer des douleurs, une vision floue et des lésions rétiniennes."
}
},
{
"@type": "Question",
"name": "Comment prévenir la toxoplasmose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez de consommer de la viande crue, lavez les fruits et légumes, et évitez les excréments de chat."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles prendre des précautions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent éviter les contacts avec les chats et consommer des aliments bien cuits."
}
},
{
"@type": "Question",
"name": "Le lavage des mains aide-t-il à prévenir la toxoplasmose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon lavage des mains après avoir manipulé de la viande ou des excréments de chat est crucial."
}
},
{
"@type": "Question",
"name": "Les chats peuvent-ils transmettre la toxoplasmose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chats sont des hôtes définitifs et peuvent excréter des oocystes dans leurs selles."
}
},
{
"@type": "Question",
"name": "Les jardins potagers présentent-ils un risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jardins peuvent être contaminés par des oocystes, surtout si des chats y ont accès."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard de la toxoplasmose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut la pyriméthamine et la sulfadiazine, souvent avec de l'acide folique."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre la toxoplasmose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces; des antiparasitaires spécifiques sont nécessaires."
}
},
{
"@type": "Question",
"name": "Le traitement est-il nécessaire pour tous les cas ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement n'est pas toujours nécessaire pour les cas asymptomatiques ou bénins."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement de la toxoplasmose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dure généralement de 4 à 6 semaines, selon la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires au traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées, des éruptions cutanées ou des troubles sanguins peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la toxoplasmose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions cérébrales, des problèmes oculaires et des infections systémiques."
}
},
{
"@type": "Question",
"name": "La toxoplasmose peut-elle affecter le fœtus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'infection pendant la grossesse peut entraîner des malformations congénitales chez le fœtus."
}
},
{
"@type": "Question",
"name": "Quels risques pour les personnes immunodéprimées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées courent un risque accru de complications graves, notamment neurologiques."
}
},
{
"@type": "Question",
"name": "La toxoplasmose peut-elle causer des problèmes neurologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des encéphalites et d'autres troubles neurologiques chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de réinfection ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, même après une infection, il est possible de contracter à nouveau la toxoplasmose."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de toxoplasmose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées, comme celles atteintes du VIH/SIDA, sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un système immunitaire affaibli, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Les jardiniers sont-ils à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jardiniers peuvent être exposés aux oocystes en manipulant le sol contaminé."
}
},
{
"@type": "Question",
"name": "Les voyageurs dans certains pays sont-ils à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs dans des régions où la toxoplasmose est endémique courent un risque accru."
}
},
{
"@type": "Question",
"name": "Les personnes qui consomment de la viande crue sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la consommation de viande crue ou mal cuite est un facteur de risque majeur pour l'infection."
}
}
]
}
]
}
Artificial Intelligence (AI) is revolutionizing many industries and becoming increasingly ubiquitous in everyday life. To empower children growing up with AI to navigate society's evolving sociotechni...
To investigate the distribution of aetiologies and outcomes in neonates with prolonged neonatal jaundice....
An observational study....
Multiple tertiary centres from the China Neonatal Genome Project....
Term infants with jaundice lasting more than 14 days or preterm infants with jaundice lasting more than 21 days were recruited between 1 June 2016 and 30 June 2020....
Aetiology and outcomes were recorded from neonates with prolonged unconjugated hyperbilirubinaemia (PUCHB) and prolonged conjugated hyperbilirubinaemia (PCHB)....
A total of 939 neonates were enrolled, and known aetiologies were identified in 84.1% of neonates (790 of 939). Among 411 neonates with PCHB, genetic disorders (27.2%, 112 of 411) were the leading aet...
Known aetiologies were identified in approximately 80% of neonates in our cohort, and their overall outcomes were favourable. Genetic aetiology should be considered a priority in neonates with PCHB or...
Including the 'voices' of people living with dementia in a meaningful way is pivotal in shaping local, national and international health and social dementia care research. The Alzheimer's Society (Uni...
Despite the dire conclusions of the Intergovernmental Panel on Climate Change (IPCC) Assessment Reports in terms of global warming and its impacts on Earth's climate, ecosystems and human society, a s...
Multiple myeloma (MM) imposes a heavy burden in China. Understanding the secular trend of MM burden and projecting its future trend could facilitate appropriate public health planning and improve the ...
Sex-specific incidence and mortality rates of MM in China from 1990 to 2019 were collected from the Global Burden of Disease 2019 study. The secular trend of MM burden was analyzed by joinpoint regres...
From 1990 to 2019, the age-standardized incidence and mortality rates of MM continued to increase in males. For females, the age-standardized rates were stable in MM incidence and decreased in MM mort...
The burden of MM in China is expected to continue to increase in the future, with significant sex difference. A comprehensive understanding of the risk characteristics and disease pattern of MM could ...
Prescribed cannabinoids are now legal in the UK and increasingly being used for a variety of conditions, with one of the most frequent conditions being chronic pain. This paper describes the character...
By 1st November 2021 data were available for 1,782 people who had sought treatment with medical cannabis as part of Project Twenty 21. The most common diagnosis among this cohort was chronic pain with...
Of the 949 people reporting chronic pain as a primary condition 54.7% were male and their average age was 42.0 years (range = 18-84). Patients reported a low quality of life and high levels of comorbi...
Consistent with findings in other national and international databases, chronic pain was the most common primary condition in this real world study of prescribed cannabinoids. There was considerable v...
This evidence implementation project aimed to identify barriers leading to needle-stick injuries (NSIs) and to develop implementation strategies to prevent NSIs in the acute ward of a hospital in cent...
The incidence rate of NSIs was 5.6% in the acute ward of a hospital in Taiwan. NSIs commonly occur during the drawing of blood, intravenous insertion, needle recapping, or performing any procedure inv...
A clinical audit was undertaken using the JBI Practical Application of Clinical Evidence System (PACES) and the Getting Research into Practice (GRiP) approach. Five audit criteria that represented bes...
According to the pre-audit concerning the use of safety-engineered injection devices and safe use and disposal of needles, there was 14-15% compliance, which indicated poor compliance with current bes...
This article suggests that standardized puncture prevention education and training enhanced nurses' awareness in the acute ward....
Over the past two decades, vaccination programmes for vaccine-preventable diseases (VPDs) have expanded across low- and middle-income countries (LMICs). However, the rise of COVID-19 resulted in globa...
Novel substances for which none or limited analytical data are available constitute a challenge for police and customs forensic laboratories. The time-consuming process of structural elucidation and a...
Healthcare ethics consultants in the Veterans Health Administration (VHA) document consults in an enterprise-wide web-based database entitled IEWeb, serving as a system of record for healthcare ethics...